Vimarsana
Biggest News Aggregation in the World

Actavis Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Actavis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Actavis Inc Today - Breaking & Trending Today

Parenteral Nutrition Market Projected to Reach US$ 10.55 Billion by 2029, Driven by a 5.9% CAGR from 2022 - Vimarsana News

Parenteral Nutrition Market Projected to Reach US$ 10.55 Billion by 2029, Driven by a 5.9% CAGR from 2022

Parenteral Nutrition market was valued at US$ 7.06 Bn. in 2022 and it is expected to reach US$ 10.55 Bn. by 2029 at a CAGR of 5.9% during the forecast period.

IONETIX announces appointment of Douglas Boothe to Board of Directors - Vimarsana News

IONETIX announces appointment of Douglas Boothe to Board of Directors

/PRNewswire/ -- IONETIX, a leading cyclotron technology and isotope manufacturing company, is pleased to announce the appointment of Douglas Boothe to its...

Lyme Disease Treatment Market is Expected to Showcase Significant Growth by 2032, Assesses DelveInsight | Key Companies - Pfizer, ModernaTX, Tarsus Pharmaceuticals, Valneva, Cortene - Vimarsana News

Lyme Disease Treatment Market is Expected to Showcase Significant Growth by 2032, Assesses DelveInsight | Key Companies - Pfizer, ModernaTX, Tarsus Pharmaceuticals, Valneva, Cortene

/PRNewswire/ -- DelveInsight's Lyme Disease Market Insights report includes a comprehensive understanding of current treatment practices, Lyme disease emerging...

D.C. Circuit Dismisses FTC Antitrust Suit: Exclusive Pharma Patent Licenses Remain Permissible Under The Patent Act - Antitrust, EU Competition - Vimarsana News

D.C. Circuit Dismisses FTC Antitrust Suit: Exclusive Pharma Patent Licenses Remain Permissible Under The Patent Act - Antitrust, EU Competition

On Friday, August 25, 2023, the U.S. Court of Appeals For The District Of Columbia Circuit affirmed dismissal of an antitrust action brought by the Federal Trade Commission...

Source: mondaq.com
Mallinckrodt Bankruptcy Reveals $21 Million Paid to Big Law Trio - Vimarsana News

Mallinckrodt Bankruptcy Reveals $21 Million Paid to Big Law Trio

Mallinckrodt PLC, a specialty pharmaceutical manufacturer that has filed for bankruptcy twice in the past three years, paid more than $21.7 million to three law firms ahead of its second insolvency filing last month.